Murray D. Krahn, MD, MSc
University of Toronto
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto
6th Floor, Room 600
144 College Street
Toronto,
ON
Canada
M5S 3M2
Papers:
2D-3
THE IMPACT OF ESTIMATING MORTALITY RATES IN COST-EFFECTIVENESS ANALYSIS.: A SIMULATION STUDY
3G-1
COST-EFFECTIVENESS ANALYSIS OF PALLIATIVE TEAM CARE FOR PATIENTS NEARING END-OF-LIFE
5N-3
THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
COST-EFFECTIVENESS OF SCREENING HEPATITIS C IN CANADA
COST-EFFECTIVENESS OF HEPATITIS B VIRUS SCREENING BEFORE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH EARLY STAGE BREAST CANCER
THE ECONOMIC IMPACT OF CLOSTRIDIUM DIFFICILE: A SYSTEMATIC REVIEW
WOUND INTERDISCIPLINARY TEAMS (WIT): A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL
IMPLEMENTATION CHALLENGES OF A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL IN WOUND CARE
ADOPTING THE PHASE-OF-CARE APPROACH TO ESTIMATE COSTS OF A SECONDARY DIAGNOSIS OF CLOSTRIDIUM DIFFICILE
COST EFFECTIVENESS ANALYSIS OF SYSTEMATIC REFERRAL TO MULTIDISCIPLINARY WOUND CARE TEAMS IN ONTARIO. EVIDENCE FROM THE WOUND INTERDISCIPLINARY TEAMS (WIT) TRIAL
ESTIMATING HEALTHCARE COSTS FOR DECISION-ANALYTIC MODELS IN ATRIAL FIBRILLATION USING ADMINISTRATIVE DATA
AM5
COMPLEX INTERVENTIONS FOR COMPARATIVE EFFECTIVENESS AND HEALTH TECHNOLOGY ASSESSMENT